SABCS 2022 | Results from a pilot study exploring cardiovascular risk evaluation for breast cancer survivors

Ilana Schlam, MD, Tufts Medical Center, Boston, MA, shares the results of a pilot investigating the feasibility of performing cardiovascular risk evaluation for breast cancer survivors. In a cohort of 60 patients, 74% were Black/African American, 14% were White and 95% Non-Hispanic. 48% of the patient cohort were found to have metabolic syndrome defined as the presence of 3 out of 5 cardiovascular risk factors waist circumference, hypertension, low HDL, high triglycerides, insulin resistance. Although all patients had an ejection fraction above 55%, 14% had an abnormal global longitudinal strain. This interview took place at the San Antonio Breast Cancer Symposium (SABCS) 2022 in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.